Viewing Study NCT01142869


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-04-03 @ 4:13 PM
Study NCT ID: NCT01142869
Status: TERMINATED
Last Update Posted: 2017-05-08
First Post: 2010-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Sponsor:
Organization:

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: